Alexei N. Pivkin

Alexei N. Pivkin

Auto-generated profile, based on publicly available information

Alexei N. Pivkin

Meshalkin National Medical Research Center

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
ABAlexander V. Bogachev-Prokophiev
Alexander V. Bogachev-Prokophiev
AAAlexander V. Afanasyev
Alexander V. Afanasyev
SZSergei I. Zheleznev
Sergei I. Zheleznev
APAlexei N. Pivkin
Alexei N. Pivkin
MFMichael S. Fomenko
Michael S. Fomenko
AKAlexander M. Karaskov
Alexander M. Karaskov

28 March 2018 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
ABAlexander V Bogachev-Prokophiev
Alexander V Bogachev-Prokophiev
AAAlexander V Afanasyev
Alexander V Afanasyev
APAlexei N Pivkin
Alexei N Pivkin
MOMichail A Ovcharov
Michail A Ovcharov
SZSergei I Zheleznev
Sergei I Zheleznev
AKAlexander M Karaskov
Alexander M Karaskov
To compare the outcomes of left atrial ablation and biatrial (BA) ablation in patients with persistent and long-standing persistent atrial fibrillation undergoing open heart surgery. Between January 2007 and December 2016, 588 consecutive patients with either persistent (20.9%) or long-standing persistent atrial fibrillation (79.1%) were enrolled in this study. To reduce between-group differences, propensity score-matched groups (156 patients/group) were obtained, with similar preoperative and perioperative characteristics. The propensity score-matched left atrial and BA groups did not differ regarding 30-day mortality (1.9% vs 0.6%; P = 0.617), 5-year overall survival (93.5 ± 2.2% vs 92.8 ± 2.9%, P = 0.998) or survival free from thromboembolic events (97.1 ± 2.8% vs 96.2 ± 2.7%, P = 0.309). The BA lesion set was more beneficial in terms of freedom from atrial arrhythmia recurrence (85.3 ± 4.5% vs 91.9 ± 3.1%, P = 0.049; hazard ratio 3.26; 95% confidence interval 1.33–7.99), but it was associated with higher pacemaker implantation rate (3.8% vs 17.3%; P < 0.001) due to sinus node dysfunction. There was no significant between-group difference regarding the incidence of atrioventricular conduction disturbances (3.2% vs 7.0%, respectively; P = 0.211). The 2 lesion sets (left atrial and BA) are associated with similar 30-day mortality, survival rates, incidences of embolic events and atrioventricular conduction disturbances. In patients with persistent atrial fibrillation, concomitant surgical ablation with BA lesion set provided better freedom from atrial arrhythmia recurrence, but BA ablation was associated with a higher incidence of sinus node dysfunction and a higher rate of pacemaker implantation.

1 January 2019 in Seminars in Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
ABAlexander V. Bogachev-Prokophiev
Alexander V. Bogachev-Prokophiev
AAAlexander V. Afanasyev
Alexander V. Afanasyev
SZSergei Zheleznev
Sergei Zheleznev
APAlexey Pivkin
Alexey Pivkin
RSRavil Sharifulin
Ravil Sharifulin
AKAlexander Karaskov
Alexander Karaskov

5 April 2018 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
RSRavil Sharifulin
Ravil Sharifulin
ABAlexander Bogachev-Prokophiev
Alexander Bogachev-Prokophiev
IDIgor Demin
Igor Demin
SZSergey Zheleznev
Sergey Zheleznev
APAlexey Pivkin
Alexey Pivkin
AKAlexander Karaskov
Alexander Karaskov
The type of conduit used for right ventricular outflow tract (RVOT) reconstruction during the Ross procedure remains problematic because of the limited availability of pulmonary allografts and the unsatisfactory long-term results associated with the use of xenografts. Polytetrafluoroethylene (PTFE) conduits have been proposed as an alternative. This study evaluated the results of RVOT reconstruction using a PTFE conduit during the Ross procedure. Between 2007 and 2015, 28 patients underwent RVOT reconstruction using PTFE conduits. The mean age of the patients was 35.9 ± 18.1 (range 4–58) years. The total root replacement technique was used in all patients. The mean PTFE conduit size was 25.3 ± 2.3 mm. The early mortality rate was 3.6% (1 patient). The mean follow-up duration was 48.5 ± 31.2 months; there were no late deaths. The transprosthetic gradients increased significantly over time. The conduit size was the only independent predictor of peak RVOT gradient progression (P = 0.02). None of the patients demonstrated significant RVOT regurgitation. One patient required an RVOT reoperation. The PTFE conduit demonstrates acceptable haemodynamic results at the mid-term follow-up and could be considered as an alternative substitute for RVOT reconstruction during the Ross procedure.

4 June 2018 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
RSRavil Sharifulin
Ravil Sharifulin
ABAlexander Bogachev-Prokophiev
Alexander Bogachev-Prokophiev
SZSergey Zheleznev
Sergey Zheleznev
IDIgor Demin
Igor Demin
APAlexey Pivkin
Alexey Pivkin
AKAlexander Karaskov
Alexander Karaskov

1 June 2016 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
AKAlexander Karaskov
Alexander Karaskov
ABAlexander V. Bogachev-Prokophiev
Alexander V. Bogachev-Prokophiev
RSRavil Sharifulin
Ravil Sharifulin
SZSergey Zheleznev
Sergey Zheleznev
IDIgor Demin
Igor Demin
IZIrina Zhuravleva
Irina Zhuravleva